Skip to product information

13th Annual Comprehensive Hematology and Oncology Review Course 2022

13th Annual Comprehensive Hematology and Oncology Review Course 2022

Regular price $65.00 USD
Regular price $65.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
13th Annual Comprehensive Hematology and Oncology Review Course 2022

13th Annual Comprehensive Hematology and Oncology Review Course 2022

Regular price $65.00
Regular price $65.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    13th Annual Comprehensive Hematology and Oncology Review Course

    • 13th Annual Comprehensive Hematology and Oncology Review Course 2022 Learn more about data supporting guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumors and malignant and nonmalignant hematologic disorders.
    • On completing the program, learners will gain a deeper understanding of the pathogenesis, diagnostic evaluation and therapeutic modalities available for a breadth of solid tumors and hematologic disorders, and the ability to integrate guideline-based treatments, new therapeutic modalities and diagnostic approaches into clinical practice.
    • This educational program is intended for physicians, advanced practice providers, nurses, pharmacists, residents and fellows interested in a comprehensive update on solid tumors and hematologic disorders, and will be of interest to those certifying or re-certifying for their boards.

    Topics :

    • Breast oncology
    • Breast Cancer – Adjuvant Therapy
    • Breast Cancer – Metastatic
    • Breast Cancer – Non-Invasive

    GI oncology

    • Anal Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Esophageal/Gastric Cancer
    • Gastrointestinal Neuroendocrine Tumors
    • Hepatocellular Cancer
    • Pancreatic Cancer
    • GU oncology
    • Bladder Cancer
    • Prostate Cancer
    • Renal Cell Carcinoma
    • Testicular Cancer

    Gynecologic oncology
    Gynecologic Oncology – Cervical and Endometrial Cancers
    Gynecologic Oncology – Ovarian Cancer

    Hematology

    • Benign White Cell Disorders
    • Bleeding Disorders
    • Hematopoietic Stem Cell Transplantation
    • Inherited & Acquired Marrow Failure
    • Iron Metabolism Disorders & Hemolytic Anemias
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Thalassemia & Hemoglobinopathies
    • Thrombocytopenia
    • Thrombosis & Anticoagulation
    • Thrombotic Microangiopathies (TTP/aHUS)
    • Transfusion Medicine
    • Consultative Hematology

    Leukemia & myelomas

    • Acute Lymphoblastic Leukemia
    • Acute Myeloid Leukemia
    • Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) & Hairy Cell Leukemia
    • Chronic Myeloid Leukemia
    • MGUS & Smoldering Myeloma
    • Multiple Myeloma

    Lymphomas

    • Aggressive Non-Hodgkin Lymphoma
    • Hodgkin Lymphoma
    • Indolent Non-Hodgkin Lymphoma
    • T-Cell Lymphoma
    • Melanoma
    • Melanoma and other Skin Cancers
    • Neuro-oncology
    • CNS Cancers
    Sarcomas

    Sarcoma

    • Supportive care & associated specialties
    • Familial Syndromes
    • Infectious Disease Complications
    • Integrative Oncology
    • Pharmacology I
    • Pharmacology II
    • Radiation Oncology – Multi-disciplinary (Breast, Lung, Colorectal, and Palliative)
    • Supportive Care
    • Thoracic, head and neck oncolog
    • Head, Neck & Thyroid Cancer
    • Mesothelioma
    • Non-Small Cell Lung Cancer – Adjuvant/Locally Advanced
    • Non-Small Cell Lung Cancer – Metastatic
    • Small Cell Lung Cancer
    File Size : 7.02 GB